Table 3.
Biomarkers | Model | Reference |
---|---|---|
Declined NO, PGE2, TNF-α, and other cytokine release activities | RAW 264.7 cells | Dong et al. [44]; Ma et al. [41] |
Reduced CD68 and F4/80 mRNA levels | Raw 264.7 | Hoo et al. [45] |
Enhanced SOD and TGF-β contents | Type 2 diabetes mellitus rat model | EIsherbiny et al. [40] |
Reduced IκBα and NF-κB p65 protein translational levels and alleviated insulin resistance | db/db obese mice | Hoo et al. [45] |
Alleviated inflammatory responses and cytokine levels via attenuating Erk1/2 and NF-κB pathways | Hepatocyte cell line; HUVEC | Figarola et al. [46]; Kim et al. [47]; Cheng et al. [48]; Xu et al. [49] |